CBD is a compound found in the cannabis plant. Unlike another component, THC, CBD is non-addictive and doesn’t cause intoxication. You may have already heard of it because of its potential as a treatment for epilepsy and multiple sclerosis.
Hallucinations and delusions are common symptoms of Parkinson’s. Around 60% of people experience these distressing symptoms. Current treatments can make other Parkinson’s symptoms worse, as they block dopamine receptors in the brain. This makes this research even more exciting as the existing information we have on CBD suggests it has no side effects.
What’s the Virtual Biotech?
The Parkinson’s Virtual Biotech is our best chance of turning promising discoveries into real treatments for people with Parkinson’s.
A biotech is a company that uses the latest technology and expertise to take the best scientific discoveries and turn them into new medical treatments.
Our Virtual Biotech operates in the same way but instead of doing it for profit, like a standard biotech, we’re doing it for people affected by Parkinson's. We don’t own our own labs, hi-tech specialist equipment or employ a team of scientists because this would be enormously expensive. Instead, we’re taking an efficient approach. Partnering with institutions and pharmaceutical companies worldwide that already have the expertise, tools and infrastructure. In a chronically underfunded area, this means more money can be put into promising treatments.
This project is the first clinical trial to go through the Virtual Biotech and the 6th project overall.
Watch the video below to find out more about the Parkinson's Virtual Biotech.
“There is a particular unmet need for novel treatments for people who experience psychosis symptoms. So people need both awareness of what people go through and also that there aren’t good enough treatments currently available.”
- Dr Sagnik Bhattcharyya